Preferred Name

Antibiotic SQ109

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95706

CAS_Registry

502487-67-4

code

C95706

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

Contributing_Source

FDA

DEFINITION

An orally available, acid-stable diamine antibiotic, with potential antimicrobial activity against a variety of bacteria including Helicobacter pylori (H. pylori) and Mycobacterium tuberculosis (M. Tuberculosis). As an ethambutol analogue with asymmetric structure, SQ109 does not act on the same target as ethambutol. However, this agent interferes with cell wall synthesis, thereby causing weakening of the cell wall and ultimately cell lysis.

FDA_UNII_Code

9AU7XUV31A

FULL_SYN

N-Geranyl-N'-(2-adamantyl)ethane-1,2-diamine

SQ-109

SQ109

Antibiotic SQ109

label

Antibiotic SQ109

NCI_Drug_Dictionary_ID

691022

PDQ_Closed_Trial_Search_ID

691022

PDQ_Open_Trial_Search_ID

691022

Preferred_Name

Antibiotic SQ109

prefixIRI

Thesaurus:C95706

prefLabel

Antibiotic SQ109

PubMedID_Primary_Reference

20385864

Semantic_Type

Antibiotic

UMLS_CUI

C1689840

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C258

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
There are currently no mappings for this class.